on 07 May 2019
Last Applicant/ Owned by
245 HAMMERSMITH ROAD
LONDON
W6 8PW
Serial Number
87850414 filed on 26th Mar 2018
Registration Number
5743057 registered on 07th May 2019
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Scientific and technological services, namely, scientific research, design, analysis and testing in the field of cancer evolution and new cancer therapies; and research and design relating thereto; industrial analysis and research services in the field of new pharmaceutical products and new cancer therapies; medical and veterinary research services involving the manipulation of cells within a labo Read More
Medical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for therapeutic purposes; providing advice and consultancy in the field of medical and veterinary therapies; providing advice and consultancy in the field of cancer therapies
N/A
N/A
Scientific and technological services, namely, scientific research, design, analysis and testing in the field of cancer evolution and new cancer therapies; and research and design relating thereto; industrial analysis and research services in the field of new pharmaceutical products and new cancer therapies; medical and veterinary research services involving the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies; scientific research into cancer evolution and clonal architecture; scientific research in human and animal cell therapy; scientific research into vaccines; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services; providing software as a service for the identification of clonal neo-antigens; providing a bioinformatics platform as a service (PAAS) featuring computer software for sequence data analysis in the field of manufacturing therapeutics; providing a bioinformatics platform featuring computer software for identifying clonal neoantigens
N/A
N/A
Bioinformatics software for sequence data analysis; computer software platforms for sequence data analysis in the fields of cancer evolution and new cancer therapies, immune response disorders, genetic conditions, infectious diseases and vascular disease
N/A
N/A
Medical and veterinary preparations for therapeutic purposes namely, pharmaceutical and veterinary preparations for the diagnosis, treatment and prevention of cancer, immune response disorders, genetic conditions, infectious diseases and vascular diseases; pharmaceutical products for the diagnosis, prevention and treatment of cancer; pharmaceutical preparations for cancer therapy; antibodies being pharmaceutical preparations for the diagnosis, treatment and prevention of cancer, immune response disorders, genetic conditions, infectious diseases and vascular diseases; vaccines; pharmaceutical preparations for cell therapy; preparations for modifying human or animal cells for medical or therapeutic purposes; preparations of blood extracted from humans or animals which have been adapted for medical or therapeutic purposes
N/A
N/A
Custom manufacture of therapeutic drugs, namely, custom manufacture of cell therapies and cancer therapies
N/A
N/A
No 87850414
No Service Mark
No 60895-428798
Yes
No
Yes
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
07th May 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
04th Aug 2021 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
07th May 2019 | REGISTERED-PRINCIPAL REGISTER |
19th Feb 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
19th Feb 2019 | PUBLISHED FOR OPPOSITION |
30th Jan 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
01st Jan 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
28th Dec 2018 | EXAMINER'S AMENDMENT ENTERED |
28th Dec 2018 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
28th Dec 2018 | EXAMINERS AMENDMENT E-MAILED |